Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reissue Patent
2008-05-06
2008-05-06
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C424S450000, C424S458000, C424S001130, C424S001210
Reissue Patent
active
10927663
ABSTRACT:
The present invention provides a method of increasing the deposition of aerosolized drug in the respiratory tract of an individual or animal, comprising the step of administering said aerosolized drug in an air mixture containing up to about 10% carbon dioxide gas.
REFERENCES:
patent: 5049388 (1991-09-01), Knight et al.
patent: 5639441 (1997-06-01), Sievers et al.
patent: 5958378 (1999-09-01), Waldrep et al.
patent: 6090407 (2000-07-01), Knight et al.
patent: 6106859 (2000-08-01), Desmore, Jr. et al.
Davis and Staag, “Interrelationships of volume and time components of individual breaths in resting man,”J. Physiol.,245:481, 1975.
Densmore et al., “Gene transfer by guanidinium-cholesterol: dioleoylphosphatidyl-ethanolamine liposome-DNA complexex in aerosol,”J. Gene Med.,1:251-264, 1999.
Knight et al., “Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice,”Cancer Chemother. Pharmacol.,44:177-186, 1999.
Koshkina et al., “Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice,”Cancer Chemother. Pharmacol.,44:187-192, 1999.
Nielsen et al., “Ventilation, CO2Production, and CO2Exposure Effects in Conscious, Restrained CF-1 Mice,”Pharmacol.&Toxicol.,72:163-168, 1993.
Persons et al., “Airway deposition of hygroscopic heterodispersed aerosols: results of a computer model,”J. Appl. Physiol.,63:1195-1204, 1987.
Persons et al., “Maximization of pulmonary hygroscopic aerosol deposition,”J. Appl. Physiol.63:1205-1209, 1987.
Schlenker, “Ventilation and Metabolism of the Djungarian Hamster (Phodopus Sungorus) and the Albino Mouse,”Comp. Biochem. Physiol.,82A(2):293-295, 1985.
Stegen et al., “Negative affect, respiratory reactivity, and somatic complaints in a CO2enriched air inhalation paradigm,”Biol. Psychol.49:109-122, 1998.
Vidgren et al., “A study of99mtechnetium-labelled beclomethasone dipropionate dilauroylphosphatidylcholine liposome aerosol in normal volunteers,”Int. J. Pharm.,115:209, 1995.
Waldrep et al., “High dose cyclosporin A and budesonide-liposome aerosols,”Int. J. Pharm.,12:27, 1997.
Co-Pending U.S. Appl. No. 09/540,916, filed Mar. 31, 2000.
Kim et al, International Journal of Pharmaceutics, 180(Dec. 1998) pp. 75-81, Pharmacodynamics of insulin in polyrthylene glycol-coated liposomes.
Knight J. Vernon
Koshkina Nadezhda
Waldrep J. Clifford
Fulbright & Jaworski L.L.P.
Haghighatian Mina
Research Development Foundation
Richter Johann
LandOfFree
Carbon dioxide enhancement of inhalation therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbon dioxide enhancement of inhalation therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbon dioxide enhancement of inhalation therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3937354